Search company, investor...


Founded Year



Acquired | Acquired

Total Raised


About Lumora

Lumora aims to develop highly distributed molecular tests to detect analytes, nucleic acids, proteins or small molecules for use in the food sector. The company works in partnership with global leaders in the fields of clinical diagnostics and industrial microbiology, licensing out core technology to help deliver products and services that meet market needs.

Headquarters Location

Bartholomews Walk Cambridgeshire Business Park, Ely

Cambridgeshire, England, CB 7 4EA,

United Kingdom


Missing: Lumora's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Lumora's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Lumora Patents

Lumora has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Molecular biology, DNA, Biotechnology, Molecular biology techniques, Polymerase chain reaction


Application Date


Grant Date



Related Topics

Molecular biology, DNA, Biotechnology, Molecular biology techniques, Polymerase chain reaction



Latest Lumora News

ERBA Molecular Ltd Product Pipeline Analysis 2018 Update Report Updated 27122018 Prices from USD $660

Nov 23, 2019

Summary ERBA Molecular Ltd ERBA Molecular, formerly Lumora Ltd, a subsidiary of Erba Diagnostics Mannheim GmbH, is a medical equipment company that offers innovative molecular diagnostics . The company provides technology that is used in medical diagnostics, agricultural, livestock and crops , food safety and pharmaceutical testing equipment, veterinary care products and personal care products. It also provides malaria diagnostic assay for screening patients, invitro diagnostics, and others. ERBA Molecular offers services such as bioinformatics, lyophilisation, testing, sample preparation, assay optimization, primer screening, commercial assay design programs, additional project support, and molecular test development process, among others. The company provides its products and services through its distributors located across the UK. ERBA Molecular is headquartered in Ely, the UK. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments The report analyzes all pipeline products in development for the company ERBA Molecular Ltd The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date The report provides detailed description of products in development, technical specification and functions The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio To formulate effective Research Development strategies Develop marketentry and market expansion strategies Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company Related Biotechnology, Pharmaceutical and Healthcare News

Lumora Frequently Asked Questions (FAQ)

  • When was Lumora founded?

    Lumora was founded in 2002.

  • Where is Lumora's headquarters?

    Lumora's headquarters is located at Bartholomews Walk, Cambridgeshire.

  • What is Lumora's latest funding round?

    Lumora's latest funding round is Acquired.

  • How much did Lumora raise?

    Lumora raised a total of $3.2M.

  • Who are the investors of Lumora?

    Investors of Lumora include ERBA Diagnostics Mannheim, Tate & Lyle Ventures, Catapult Ventures, Cambridge Enterprise Seed Funds and University of Cambridge Challenge Fund.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.